GE HealthCare traces its origins to 1892 and operates today as a public company with annual revenue of $20.6 billion and approximately 54,000 employees. Its four main business segments - Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics - form an integrated precision care platform deployed across more than 160 countries. The company maintains an installed base exceeding 5 million devices and serves over one billion patients each year.
AI and software development are central to the company's strategy. GE HealthCare's Imaging segment alone offers more than 200 software applications, and the organisation's technical work spans intelligent medical devices, AI-powered clinical tools, and pharmaceutical diagnostics. Annual R&D and product investment exceeds $5.1 billion, supporting a portfolio of over 11,000 patents worldwide.
Headquartered in the United States with a global footprint reaching major medical centres and remote regions alike, GE HealthCare focuses on enabling clinicians to deliver more personalised, precise patient care while improving hospital efficiency and clinical outcomes.
